Symbol Name ID |
Irf2
interferon regulatory factor 2 MGI:96591 |
Allelic Composition Genetic Background |
Annotated Term | Reference |
Irf2tm1Mak/Irf2+ either: (involves: 129S2/SvPas * C57BL/6J) or (involves: 129S2/SvPas * C57BL/6J * DBA/2) |
no abnormal phenotype detected | J:64286 |
Irf2tm1Mak/Irf2tm1Mak either: (involves: 129S2/SvPas * C57BL/6J) or (involves: 129S2/SvPas * C57BL/6J * DBA/2) |
abnormal immune system physiology | J:64286 |
abnormal response to infection | J:64286 | |
decreased B cell proliferation | J:64286 | |
decreased IgG2a level | J:64286 | |
decreased mature B cell number | J:64286 | |
decreased T cell number | J:64286 | |
normal immune system phenotype | J:64286 | |
premature death | J:64286 | |
skin lesions | J:64286 | |
Irf2tm1Mak/Irf2tm1Mak involves: 129S2/SvPas * C57BL/6 |
dermatitis | J:66034 |
enlarged inguinal lymph nodes | J:66034 | |
increased memory T cell number | J:66034 | |
lymph node hyperplasia | J:66034 | |
premature hair loss | J:66034 | |
reddish skin | J:66034 | |
skin fibrosis | J:66034 | |
skin lesions | J:66034 | |
thick epidermis | J:66034 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 12/17/2024 MGI 6.24 |
![]() |
|